Sponsored Links
| Cellectis And VitamFero Collaborate To Develop Vaccines Against Parasitic Infection |
 |
 |
 |
| Medical News - Immune System and Vaccines | |||
|
Cellectis (Alternext: ALCLS), the genome engineering specialist, and VitamFero, a biotech company of the Genopole® portfolio developing new vaccines against parasite infections, today announced the signing of a research, development and licensing partnership agreement... Read more: Immune System / Vaccines News From Medical News Today
|